3118 logo

Level Biotechnology Inc. Stock Price

TPEX:3118 Community·NT$1.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

3118 Share Price Performance

NT$0
-31.10 (-100.00%)
NT$0
-31.10 (-100.00%)
Price NT$0

3118 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

2 Risks
2 Rewards

Level Biotechnology Inc. Key Details

NT$736.6m

Revenue

NT$478.9m

Cost of Revenue

NT$257.7m

Gross Profit

NT$178.0m

Other Expenses

NT$79.7m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
2.46
34.99%
10.82%
0%
View Full Analysis

About 3118

Founded
1989
Employees
128
CEO
Chun Long Qiu
WebsiteView website
www.level.com.tw

Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. The company markets and distributes biomedical precision equipment. It also provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. In addition, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan.

Recent 3118 News & Updates

Recent updates

No updates